InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.048 0.001 (2.04%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 Emerald Partners with Mt Sinai for Openly Service 17 Sep 2020 9:52AM $0.088 $0.048 fallen by 45.45%
$39 Emerald Receives TGA Registration for Openly App 15 Sep 2020 2:34PM $0.084 $0.048 fallen by 42.86%
$39 Emerald Supports Interim Decision for Evidence-Based OTC CBD 11 Sep 2020 9:55AM $0.082 $0.048 fallen by 41.46%
$39 Appendix 2A and Notice Under Section 708A 7 Sep 2020 9:42AM $0.087 $0.048 fallen by 44.83%
$39 Issue of Placement Shares 7 Sep 2020 9:41AM $0.087 $0.048 fallen by 44.83%
$39 Change of Registered Office 2 Sep 2020 11:31AM $0.090 $0.048 fallen by 46.67%
$39 Preliminary Final Report and Full Year Statutory Accounts 31 Aug 2020 5:10PM $0.085 $0.048 fallen by 43.53%
$39 Proposed issue of Securities - EMD 28 Aug 2020 1:13PM $0.099 $0.048 fallen by 51.52%
$39 Emerald Clinics Successfully Raises $2.2m in Placement 28 Aug 2020 1:13PM $0.099 $0.048 fallen by 51.52%
$39 Trading Halt 27 Aug 2020 9:39AM $0.099 $0.048 fallen by 51.52%
$39 Company Update 19 Aug 2020 9:15AM $0.080 $0.048 fallen by 40%
$39 Letter to Shareholders - General Meeting 14 Aug 2020 7:06PM $0.079 $0.048 fallen by 39.24%
$39 Notice of General Meeting/Proxy Form 14 Aug 2020 7:06PM $0.079 $0.048 fallen by 39.24%
$39 Record Appointments International Expansion and Name Change 14 Aug 2020 9:21AM $0.061 $0.048 fallen by 21.31%
$39 Emerald Signs RWE Contract with Canopy Growth UK Company 10 Aug 2020 9:26AM $0.043 $0.048 risen by 11.63%
$39 Appendix 4C - Quarterly 31 Jul 2020 8:44AM $0.048 $0.048 fallen by 0%
$39 Investor Presentation 25 Jun 2020 9:18AM $0.051 $0.048 fallen by 5.88%
$39 Emerald Clinics Investor Webinar 22 Jun 2020 2:49PM $0.051 $0.048 fallen by 5.88%
$39 EMDs Digital Health Platform Expands with New Technology 22 Jun 2020 9:23AM $0.056 $0.048 fallen by 14.29%
$39 Trading Halt 18 Jun 2020 9:48AM $0.056 $0.048 fallen by 14.29%
$39 EMD Program Manager of National Clinical Data and Analytics 11 May 2020 9:59AM $0.061 $0.048 fallen by 21.31%
$39 Appendix 4C - Quarterly 30 Apr 2020 9:23AM $0.062 $0.048 fallen by 22.58%
$39 Change in substantial holding CD 20 Apr 2020 10:36AM $0.069 $0.048 fallen by 30.43%
$39 COVID-19 Market Update 26 Mar 2020 10:28AM $0.045 $0.048 risen by 6.67%
$39 Change of Director's Interest Notice SW 17 Mar 2020 12:17PM $0.050 $0.048 fallen by 4%

501 - 525 of 552 results

Page 21 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.